Clinical Trials Insight: 700028547
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2008
At a glance
- Drugs Elpetrigine (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors Jazz Pharmaceuticals Inc
- 13 Feb 2008 Status changed from in progress to completed according to Jazz Pharmaceuticals media release.
- 16 Nov 2007 New trial record.
- 06 Nov 2007 This trial is expected to be completed in the fourth quarter in 2007.